Cobalt Light Systems launches new US company
24 March 2015 | By Cobalt Light Systems
Cobalt Light Systems, Ltd announces the formation of a US subsidiary company to support increasing demand for its novel pharmaceutical products...
List view / Grid view
News
Thomson Reuters names most promising drugs of 2015
24 March 2015 | By Victoria White
The Intellectual Property and Science business of Thomson Reuters has released the 2015 edition of its annual Drugs to Watch report...
Aerie Pharmaceuticals completes enrollment in second Phase 3 registration trial of Rhopressa
24 March 2015 | By Victoria White
Aerie Pharmaceuticals has announced the completion of enrollment in the Company’s second Phase 3 registration trial (“Rocket 2”) of Rhopressa...
EU Disease Lens brings visibility and insight into the most critical diseases
24 March 2015 | By Victoria White
Janssen Health Policy Centre (Janssen Pharmaceutica NV) today unveiled the EU Disease Lens: a digital dashboard that brings insight into 15 major diseases...
Biogen Idec presents positive interim results from Phase 1b study of investigational Alzheimer’s Disease treatment aducanumab
23 March 2015 | By Victoria White
Biogen Idec has announced data from the Phase 1b study of aducanumab, in which the drug demonstrated positive results in patients with prodromal or mild AD...
PANalytical launched new compact benchtop XRF system for pharmaceutical catalysts analysis
23 March 2015 | By PANalytical
PANalytical launched a new Epsilon 1 XRF analyzer at last year’s meeting of the American Association of Pharmaceutical Sciences (AAPS) in California...
Vaccination for measles must be scaled up in Ebola-affected countries, says the World Health Organization
23 March 2015 | By Victoria White
A growing risk of outbreaks of vaccine-preventable diseases in countries affected by Ebola must be countered by the scaling up of routine immunisation...
Heparin helps in understanding a natural HIV barrier
23 March 2015 | By Victoria White
Heparin, a blood thinning agent, is helping researchers at the University of East Anglia (UEA) understand more about the body’s natural barriers to HIV...
First-in-class type 2 diabetes treatment GLYXAMBI tablets for adults now available in U.S. pharmacies
23 March 2015 | By Victoria White
GLYXAMBI® tablets are now available by prescription in the US. GLYXAMBI offers improved glycemic control as an adjunct to diet and exercise...
London NHS Trust teams up with Premaitha Health to create the UK’s first centre of excellence for non-invasive prenatal screening (NIPT)
23 March 2015 | By Victoria White
Partnership between the NHS Trust and Premaitha Health means St George's Hospital, London, will be first NHS facility to offer NIPT screening...
Merck supports schistosomiasis education in Mozambique
23 March 2015 | By Victoria White
Merck is fighting schistosomiasis in Mozambique, providing WHO with praziquantel tablets free of charge and presenting 20,000 educational brochures...
Lilly and Innovent Biologics announce a strategic alliance to bring potential oncology therapies to patients in China and around the world
20 March 2015 | By Victoria White
Lilly and Innovent announce one of the largest biotech drug development collaborations in China to date between a multi-national and domestic company...
Scientists called to reduce antibiotic use in experiments
20 March 2015 | By Victoria White
Scientists should reduce antibiotic use in lab experiments - according to a researcher from UEA’s Norwich Medical School...
HORIBA Scientific launches Swift v.2 for ultra fast, high definition confocal raman imaging
20 March 2015 | By HORIBA
HORIBA Scientific, global leader in Raman and optical spectroscopy systems for over 50 years, announces the release of their newest SWIFT v2 ultra fast confocal Raman imaging module...
Global Type 1 Diabetes (T1D) treatment market value doubling to $13.6 billion by 2023, says GlobalData
20 March 2015 | By Victoria White
The global treatment market for Type 1 Diabetes (T1D) will expand from $6.6 billion in 2013 to an estimated $13.6 billion by 2023 according to GlobalData...
